{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T18:11:46Z","timestamp":1755799906258,"version":"3.44.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,19]]},"DOI":"10.7759\/cureus.90536","type":"journal-article","created":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T04:55:39Z","timestamp":1755665739000},"source":"Crossref","is-referenced-by-count":0,"title":["Association of the Glycemia Risk Index With Glycemic Metrics and Sensor Usage in a Real-World Pediatric Population With Low Hypoglycemia Rates in Saudi Arabia"],"prefix":"10.7759","author":[{"given":"Lamya M","family":"Alzubaidi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faisal S","family":"El Enezi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afaf I","family":"Alsagheir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muna H","family":"Hassanein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullah M","family":"Alsoheimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullah M","family":"Arabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amera S","family":"Alrshood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulmohsen K","family":"Bakhsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41390-024-03107-5","article-title":"Global, regional, and national burden of type 1 diabetes in adolescents and young adults","volume":"97","author":"Gong B","year":"2025","unstructured":"Gong B, Yang W, Xing Y, Lai Y, Shan Z. Global, regional, and national burden of type 1 diabetes in adolescents and young adults. Pediatr Res. 2025, 97:568-76. 10.1038\/s41390-024-03107-5","journal-title":"Pediatr Res"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2020.12.013","article-title":"Managing type 1 diabetes among Saudi adults on insulin pump therapy during the COVID-19 lockdown","volume":"15","author":"Magliah SF","year":"2021","unstructured":"Magliah SF, Zarif HA, Althubaiti A, Sabban MF. Managing type 1 diabetes among Saudi adults on insulin pump therapy during the COVID-19 lockdown. Diabetes Metab Syndr. 2021, 15:63-8. 10.1016\/j.dsx.2020.12.013","journal-title":"Diabetes Metab Syndr"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.54905\/disssi\/v26i127\/ms369e2441","article-title":"Effectiveness of the insulin pump on type 1 diabetes in controlling HbA1C in Riyadh, Saudi Arabia","volume":"26","author":"Brazanji NA","year":"2022","unstructured":"Brazanji NA, Al-Nafisi A. Effectiveness of the insulin pump on type 1 diabetes in controlling HbA1C in Riyadh, Saudi Arabia. Med Sci. 2022, 26:1-8. 10.54905\/disssi\/v26i127\/ms369e2441","journal-title":"Med Sci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2337\/dci20-0032","article-title":"Continuous glucose monitoring-derived data report\u2014simply a better management tool","volume":"43","author":"Battelino T","year":"2020","unstructured":"Battelino T, Bergenstal RM. Continuous glucose monitoring-derived data report\u2014simply a better management tool. Diabetes Care. 2020, 43:2327-9. 10.2337\/dci20-0032","journal-title":"Diabetes Care"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2337\/dc17-1600","article-title":"International consensus on use of continuous glucose monitoring","volume":"40","author":"Danne T","year":"2017","unstructured":"Danne T, Nimri R, Battelino T, et al.. International consensus on use of continuous glucose monitoring. Diabetes Care. 2017, 40:1631-40. 10.2337\/dc17-1600","journal-title":"Diabetes Care"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/pedi.12737","article-title":"ISPAD clinical practice consensus guidelines 2018: glycemic control targets and glucose monitoring for children, adolescents, and young adults with diabetes","volume":"19","author":"DiMeglio LA","year":"2018","unstructured":"DiMeglio LA, Acerini CL, Codner E, Craig ME, Hofer SE, Pillay K, Maahs DM. ISPAD clinical practice consensus guidelines 2018: glycemic control targets and glucose monitoring for children, adolescents, and young adults with diabetes. Pediatr Diabetes. 2018, 19:105-14. 10.1111\/pedi.12737","journal-title":"Pediatr Diabetes"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2337\/dci19-0028","article-title":"Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range","volume":"42","author":"Battelino T","year":"2019","unstructured":"Battelino T, Danne T, Bergenstal RM, et al.. Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range. Diabetes Care. 2019, 42:1593-603. 10.2337\/dci19-0028","journal-title":"Diabetes Care"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2023.0040","article-title":"Glycemia Risk Index as a novel metric to evaluate the safety of glycemic control in children and adolescents with type 1 diabetes: an observational, multicenter, real-life cohort study","volume":"25","author":"Piona C","year":"2023","unstructured":"Piona C, Marigliano M, Roncar\u00e0 C, et al.. Glycemia Risk Index as a novel metric to evaluate the safety of glycemic control in children and adolescents with type 1 diabetes: an observational, multicenter, real-life cohort study. Diabetes Technol Ther. 2023, 25:507-12. 10.1089\/dia.2023.0040","journal-title":"Diabetes Technol Ther"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-019-05027-0","article-title":"Positioning time in range in diabetes management","volume":"63","author":"Advani A","year":"2020","unstructured":"Advani A. Positioning time in range in diabetes management. Diabetologia. 2020, 63:242-52. 10.1007\/s00125-019-05027-0","journal-title":"Diabetologia"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-020-00529-z","article-title":"Time in range: a new parameter to evaluate blood glucose control in patients with diabetes","volume":"12","author":"Gabbay MA","year":"2020","unstructured":"Gabbay MA, Rodacki M, Calliari LE, et al.. Time in range: a new parameter to evaluate blood glucose control in patients with diabetes. Diabetol Metab Syndr. 2020, 12:22. 10.1186\/s13098-020-00529-z","journal-title":"Diabetol Metab Syndr"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1177\/19322968221085273","article-title":"A Glycemia Risk Index (GRI) of hypoglycemia and hyperglycemia for continuous glucose monitoring validated by clinician ratings","volume":"17","author":"Klonoff DC","year":"2023","unstructured":"Klonoff DC, Wang J, Rodbard D, et al.. A Glycemia Risk Index (GRI) of hypoglycemia and hyperglycemia for continuous glucose monitoring validated by clinician ratings. J Diabetes Sci Technol. 2023, 17:1226-42. 10.1177\/19322968221085273","journal-title":"J Diabetes Sci Technol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s40200-025-01569-w","article-title":"Evaluation of Glycemia Risk Index and continuous glucose monitoring-derived metrics in type 1 diabetes: a real-world observational study","volume":"24","author":"Al Hayek A","year":"2025","unstructured":"Al Hayek A, Al Mashali M, Al Dawish MA. Evaluation of Glycemia Risk Index and continuous glucose monitoring-derived metrics in type 1 diabetes: a real-world observational study. J Diabetes Metab Disord. 2025, 24:59. 10.1007\/s40200-025-01569-w","journal-title":"J Diabetes Metab Disord"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-023-03511-7","article-title":"Impact of glucose variability on the assessment of the glycemia risk index (GRI) and classic glycemic metrics","volume":"82","author":"P\u00e9rez-L\u00f3pez P","year":"2023","unstructured":"P\u00e9rez-L\u00f3pez P, F\u00e9rnandez-Velasco P, Bahillo-Curieses P, de Luis D, D\u00edaz-Soto G. Impact of glucose variability on the assessment of the glycemia risk index (GRI) and classic glycemic metrics. Endocrine. 2023, 82:560-8. 10.1007\/s12020-023-03511-7","journal-title":"Endocrine"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1177\/19322968231208957","article-title":"Sensitivity of the glycemia risk index to effects of automated insulin delivery initiation","volume":"18","author":"Donaldson LE","year":"2024","unstructured":"Donaldson LE, Vogrin S, McAuley SA. Sensitivity of the glycemia risk index to effects of automated insulin delivery initiation. J Diabetes Sci Technol. 2024, 18:242-3. 10.1177\/19322968231208957","journal-title":"J Diabetes Sci Technol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1177\/19322968241231307","article-title":"Hybrid closed-loop versus manual insulin delivery in adults with type 1 diabetes: a post hoc analysis using the glycemia risk index","volume":"18","author":"Lee MH","year":"2024","unstructured":"Lee MH, Vogrin S, Jones TW, O'Neal DN. Hybrid closed-loop versus manual insulin delivery in adults with type 1 diabetes: a post hoc analysis using the glycemia risk index. J Diabetes Sci Technol. 2024, 18:764-70. 10.1177\/19322968241231307","journal-title":"J Diabetes Sci Technol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-024-01946-w","article-title":"Impact on Glycemia Risk Index and other metrics in type 1 adult patients switching to advanced hybrid closed-loop systems: a one-year real-life experience","volume":"29","author":"Resmini E","year":"2024","unstructured":"Resmini E, Zarra E, Dotti S, et al.. Impact on Glycemia Risk Index and other metrics in type 1 adult patients switching to advanced hybrid closed-loop systems: a one-year real-life experience. Eur J Med Res. 2024, 29:365. 10.1186\/s40001-024-01946-w","journal-title":"Eur J Med Res"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1388245","article-title":"Glycemic variability through the perspective of the glycemia risk index and time in range and their association with glycated hemoglobin A1c in pediatric patients on sensor-augmented pump therapy","volume":"15","author":"Bukara-Radujkovic G","year":"2024","unstructured":"Bukara-Radujkovic G, Miljkovic V. Glycemic variability through the perspective of the glycemia risk index and time in range and their association with glycated hemoglobin A1c in pediatric patients on sensor-augmented pump therapy. Front Endocrinol (Lausanne). 2024, 15:1388245. 10.3389\/fendo.2024.1388245","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2022.0104","article-title":"Essential continuous glucose monitoring metrics: the principal dimensions of glycemic control in diabetes","volume":"24","author":"Montaser E","year":"2022","unstructured":"Montaser E, Fabris C, Kovatchev B. Essential continuous glucose monitoring metrics: the principal dimensions of glycemic control in diabetes. Diabetes Technol Ther. 2022, 24:797-804. 10.1089\/dia.2022.0104","journal-title":"Diabetes Technol Ther"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2017.3","article-title":"Metrics for glycaemic control \u2014 from HbA1c to continuous glucose monitoring","volume":"13","author":"Kovatchev BP","year":"2017","unstructured":"Kovatchev BP. Metrics for glycaemic control \u2014 from HbA1c to continuous glucose monitoring. Nat Rev Endocrinol. 2017, 13:425-36. 10.1038\/nrendo.2017.3","journal-title":"Nat Rev Endocrinol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1097\/CM9.0000000000002983","article-title":"Implications of glycemic risk index across different levels of glycated hemoglobin (HbA1c) in type 1 diabetes","volume":"137","author":"He B","year":"2024","unstructured":"He B, Fan L, Deng C, Liu F, Xie Y, Zhou Z, Li X. Implications of glycemic risk index across different levels of glycated hemoglobin (HbA1c) in type 1 diabetes. Chin Med J (Engl). 2024, 137:481-3. 10.1097\/CM9.0000000000002983","journal-title":"Chin Med J (Engl)"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1177\/19322968221128565","article-title":"Efficacy of a hybrid closed-loop solution in patients with excessive time in hypoglycaemia: a post hoc analysis of trials with DBLG1 system","volume":"18","author":"Benhamou PY","year":"2024","unstructured":"Benhamou PY, Adenis A, Tourki Y, et al.. Efficacy of a hybrid closed-loop solution in patients with excessive time in hypoglycaemia: a post hoc analysis of trials with DBLG1 system. J Diabetes Sci Technol. 2024, 18:372-9. 10.1177\/19322968221128565","journal-title":"J Diabetes Sci Technol"},{"unstructured":"Abbott Diabetes Care. FreeStyle Libre 2 System user\u2019s manual. (2020). Accessed. April 23, 2025: https:\/\/www.freestyle.abbott\/sa-en\/support\/manuals.html.","key":"ref22"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.2337\/dc09-0108","article-title":"The effect of continuous glucose monitoring in well-controlled type 1 diabetes","volume":"32","author":"Beck RW","year":"2009","unstructured":"Beck RW, Hirsch IB, Laffel L, et al.. The effect of continuous glucose monitoring in well-controlled type 1 diabetes. Diabetes Care. 2009, 32:1378-83. 10.2337\/dc09-0108","journal-title":"Diabetes Care"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.2337\/dc09-0750","article-title":"Incremental value of continuous glucose monitoring when starting pump therapy in patients with poorly controlled type 1 diabetes: the RealTrend study","volume":"32","author":"Raccah D","year":"2009","unstructured":"Raccah D, Sulmont V, Reznik Y, et al.. Incremental value of continuous glucose monitoring when starting pump therapy in patients with poorly controlled type 1 diabetes: the RealTrend study. Diabetes Care. 2009, 32:2245-50. 10.2337\/dc09-0750","journal-title":"Diabetes Care"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d3805","article-title":"Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data","volume":"343","author":"Pickup JC","year":"2011","unstructured":"Pickup JC, Freeman SC, Sutton AJ. Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data. BMJ. 2011, 343:d3805. 10.1136\/bmj.d3805","journal-title":"BMJ"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.2337\/dc11-1746","article-title":"A randomized clinical trial to assess the efficacy and safety of real-time continuous glucose monitoring in the management of type 1 diabetes in young children aged 4 to <10 years","volume":"35","author":"Mauras N","year":"2012","unstructured":"Mauras N, Beck R, Xing D, et al.. A randomized clinical trial to assess the efficacy and safety of real-time continuous glucose monitoring in the management of type 1 diabetes in young children aged 4 to &lt;10 years. Diabetes Care. 2012, 35:204-10. 10.2337\/dc11-1746","journal-title":"Diabetes Care"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/397937-association-of-the-glycemia-risk-index-with-glycemic-metrics-and-sensor-usage-in-a-real-world-pediatric-population-with-low-hypoglycemia-rates-in-saudi-arabia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T04:55:40Z","timestamp":1755665740000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/397937-association-of-the-glycemia-risk-index-with-glycemic-metrics-and-sensor-usage-in-a-real-world-pediatric-population-with-low-hypoglycemia-rates-in-saudi-arabia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,19]]},"references-count":26,"URL":"https:\/\/doi.org\/10.7759\/cureus.90536","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,8,19]]}}}